AI
Tuesday, March 24, 2009 7:50:00 AM
Has Genta released any PR...
...on their financial situation, stating that they've come up with non-dilutive financing? You would think that if they had, they'd let investors know right away...right? This was a major concern during the conference call, and after reading the S-1/A, it appears that Genta is completely out of money by the end of this month, if not already. Notice the image below is their financials as of the END OF QUARTER 3 2008. That was 6 months ago.
Our business will suffer if we fail to obtain timely funding.
Our operations to date have required significant cash expenditures. Prior to completion of this offering, we have less than two months operating cash remaining. Our future capital requirements will depend on the results of our research and development activities, preclinical studies and clinical trials, competitive and technological advances, and regulatory activities of the FDA and other regulatory authorities. In order to commercialize our products, seek new product candidates and continue our research and development programs, we will need to raise significant additional funds irrespective of market conditions.
If we are unable to raise additional funds, we will need to do one or more of the following:
• delay, scale back or eliminate some or all of our research and product development programs;
• license third parties to develop and commercialize products or technologies that we would otherwise seek to develop and commercialize ourselves;
• attempt to sell our company;
• cease operations; or
• declare bankruptcy
Presently, with no further financing, we will run out of funds in the first quarter of 2009. We currently do not have any additional financing in place.
http://www.sec.gov/Archives/edgar/data/880643/000095012309004228/y01236a1sv1za.htm
(bottom of page 13)
...on their financial situation, stating that they've come up with non-dilutive financing? You would think that if they had, they'd let investors know right away...right? This was a major concern during the conference call, and after reading the S-1/A, it appears that Genta is completely out of money by the end of this month, if not already. Notice the image below is their financials as of the END OF QUARTER 3 2008. That was 6 months ago.
Our business will suffer if we fail to obtain timely funding.
Our operations to date have required significant cash expenditures. Prior to completion of this offering, we have less than two months operating cash remaining. Our future capital requirements will depend on the results of our research and development activities, preclinical studies and clinical trials, competitive and technological advances, and regulatory activities of the FDA and other regulatory authorities. In order to commercialize our products, seek new product candidates and continue our research and development programs, we will need to raise significant additional funds irrespective of market conditions.
If we are unable to raise additional funds, we will need to do one or more of the following:
• delay, scale back or eliminate some or all of our research and product development programs;
• license third parties to develop and commercialize products or technologies that we would otherwise seek to develop and commercialize ourselves;
• attempt to sell our company;
• cease operations; or
• declare bankruptcy
Presently, with no further financing, we will run out of funds in the first quarter of 2009. We currently do not have any additional financing in place.
http://www.sec.gov/Archives/edgar/data/880643/000095012309004228/y01236a1sv1za.htm
(bottom of page 13)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
